source
- Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillSet to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.BioPharma Dive · 15d ago↗ source
- STAT+: Anthropic’s Claude Science is coming for Kendall SquareAI still has the potential to do more than reduce corporate head counts. Watch out, Kendall Square.STAT · 15d ago↗ source
- Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces responseThe Ebola outbreak in eastern Congo “continues to outpace the response efforts,” the WHO’s emergencies chief said on Tuesday after returning from a trip to one of the worst hit…STAT · 15d ago